During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...

Respiratory syncytial virus (RSV) is a common viral infection that may lead to serious complications in certain groups. Since 2023, vaccines are now available and are highly recommended ...

For the week ending Jan. 25, seasonal flu activity remains high and increasing. Clinical laboratories tested 129,378 ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022 to 2023 season.

In the wake of multiple cases of human metapneumovirus (hMPV) in India, multiple questions about its causes and symptoms seem ...

The CDC monitors RSV through the Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET), which comprises 161 counties and county-equivalents in 13 states. The network ...

The percentage of positive tests as of Dec. 28, 2024, was 7.1% for COVID-19, 18.7% for flu and 12.8% for RSV. Respiratory syncytial virus, or RSV, is a common respiratory virus that infects the ...

This new vaccine will help protect newborn babies from illness caused by RSV, a common virus that affects the nose, throat, and lungs. Bakewell mum-to-be Pritee Shrestha said she was pleased to be ...

No writing assistance was utilized in the production of this manuscript. Worldwide, respiratory syncytial virus (RSV) is the most important cause of bronchiolitis and pneumonia in infants.